Company profilePharmaceutical#619 of 1,318 in Pakistan✓ No DRAP alerts

WISDOM THERAPEUTICS

Pharmaceutical company · 18 brands · 15 molecules

Ranked #51 of 51 companies in Antimycotics Systemic Use

18 registered products 17 pharmaceutical brands 15 distinct molecules 0 DRAP alerts

Company overview

18
registered products
17
pharmaceutical brands
15
distinct molecules
1
therapeutic classes
0
DRAP alerts

WISDOM THERAPEUTICS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 18 product registrations across 15 distinct molecules. Its portfolio is concentrated in Antimycotics Systemic Use. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Therapeutic classes

Antimycotics Systemic Use · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.12 shared molecules
SHROOQ PHARMACEUTICALS10 shared molecules
LINTA9 shared molecules
CRYSTOLITE PHARMACEUTICALS9 shared molecules
VALOR PHARMACEUTICALS9 shared molecules
Albro Pharmaceuticals8 shared molecules

Get the full profile for WISDOM

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.